Alkyltriphenylphosphonium Binding to Cardiolipin Triggers Oncosis in Cancer Cells
Advanced Science · 2026
DOI: 10.1002/advs.202510237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Jin Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Cardiolipins, Organophosphorus Compounds, Mitochondria, Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, Taishan Scholar Project of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Mitochondria, pivotal for cellular bioenergetics and signaling, are attractive targets for cancer therapy. Triphenylphosphonium (TPP + ) is a widely used mitochondrial‐targeting ligand, yet its intrinsic bioactivity and mechanism remain underexplored. Here we demonstrate that alkylated TPP + derivatives exhibit chain length‐dependent anticancer activity, with TPP + ‐C 14 showing superior efficacy both in vitro and in vivo. Mechanistically, TPP + ‐C 14 selectively binds to cardiolipin, a key phospholipid in the inner mitochondrial membrane, through electrostatic and hydrophobic interactions, as validated by biolayer interferometry, competitive binding assays, and molecular dynamics simulations. This binding impairs cardiolipin function, leading to mitochondrial membrane potential collapse, adenosine triphosphate depletion, metabolic reprogramming, and ultimately mitochondrial dysfunction. Intriguingly, TPP + ‐C 14 induces oncosis in cancer cells, rather than apoptosis or autophagy, by activating the endoplasmic reticulum stress pathway. These findings reveal a novel bioactive mechanism for TPP + beyond its intrinsic mitochondrial targeting property, providing a foundation for next‐generation mitochondrial‐targeted anticancer strategies that could precisely modulate mitochondrial functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning, China.
- Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (MOE), Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, School of Pharmaceutical Sciences, Cheeloo College of…
- Institute of Medical Sciences, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
- School of Life and Health Sciences, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, Shandong, China.
ORCID-Profile: Zhao Ma
Förderung
- Natural Science Foundation of Shandong Province
- Taishan Scholar Project of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Zheng, H., Lin, Y., Zhao, Z., Mai, Y., Lou, Z., Liu, Q., Ma, Z., & Wu, C. (2026). Alkyltriphenylphosphonium Binding to Cardiolipin Triggers Oncosis in Cancer Cells. Advanced Science. https://doi.org/10.1002/advs.202510237
Vancouver
Li J, Zheng H, Lin Y, Zhao Z, Mai Y, Lou Z, et al. Alkyltriphenylphosphonium Binding to Cardiolipin Triggers Oncosis in Cancer Cells. Advanced Science. 2026. doi:10.1002/advs.202510237
BibTeX
@article{Li2026,
author = {Li, Jin and Zheng, Hang and Lin, Yuxing and Zhao, Ziwei and Mai, Yijia and Lou, Zhangrong and Liu, Qiang and Ma, Zhao and Wu, Chengjun},
title = {Alkyltriphenylphosphonium Binding to Cardiolipin Triggers Oncosis in Cancer Cells},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202510237}
}
EUVIMED